The English Studies curriculum must explore technology’s humanising potential and offer paths toward critical inquiry and ...
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with ...
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic ...
Weight-loss medications reduced body weight in children and teens, but the sample size was too small to make conclusions ...
Xencor remains a 'Strong Buy' in my view despite the stock's 60% performance decline. Click here to find out why XNCR stock ...
AMO Pharma Limited ("AMO Pharma"), a privately held clinical-stage specialty biopharmaceutical company focusing on rare ...
Stability and Change in Gender Identity and Sexual Orientation Across Childhood and Adolescence” was published in the ...
New data suggest antithymocyte globulin, verapamil, and baricitinib might help preserve beta cell function in new-onset type ...
Ryan Quigley, CEO of Inizio, discusses how his experience as Chief Operating Officer shaped his journey to CEO.
ENDO 2025 featured the latest research on novel therapies for adrenal and neuroendocrine conditions, new data on various ...
Connecticut officials say the student loan changes will keep people in debt far longer than they needed to be and limit ...
Stockhead on MSN
Dr Boreham’s Crucible: A ‘clear route to market’ could emerge beyond this rocky share price road
This biotech's recent stroke drug trial results appeared to disappoint investors, but there was plenty of positive nuance in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results